Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for RNA

Stock Name	Avidity Biosciences Inc
Ticker	RNA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US05370A1088

Show aggregate RNA holdings

News associated with RNA

Avidity Biosciences (NASDAQ:RNA) Coverage Initiated by Analysts at Roth Capital: Roth Capital started coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report released on Wednesday, Marketbeat.com reports. The brokerage issued a buy rating and a $62.00 price objective on the biotechnology company’s stock. A number of other equities analysts also recently weighed in on the stock. Wolfe Research began coverage on […] - 2025-09-18 04:26:54
Bank of America Raises Avidity Biosciences (NASDAQ:RNA) Price Target to $65.00: Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its target price raised by research analysts at Bank of America from $56.00 to $65.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price objective suggests a potential upside of 56.85% from […] - 2025-09-17 02:38:42
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 14:49:56
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 12:32:21
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 10:58:14
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 10:14:12
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 08:20:54
Brokerages Set Avidity Biosciences, Inc. (NASDAQ:RNA) Price Target at $67.00: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has been assigned a consensus rating of “Buy” from the eighteen ratings firms that are presently covering the firm, Marketbeat.com reports. Seventeen equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 […] - 2025-09-12 02:32:51
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-11 20:38:25
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 20:20:22
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 19:48:54
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 14:56:29
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 14:56:29
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 14:31:03
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 14:31:02
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 12:55:25
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 12:50:08
Avidity Biosciences (NASDAQ:RNA) Stock Price Down 4.2% After Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price dropped 4.2% on Monday after an insider sold shares in the company. The stock traded as low as $44.55 and last traded at $44.51. Approximately 1,095,468 shares changed hands during trading, a decline of 40% from the average daily volume of 1,834,316 shares. The stock […] - 2025-08-20 02:34:50
Avidity Biosciences (NASDAQ:RNA) Shares Gap Down on Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down prior to trading on Monday after an insider sold shares in the company. The stock had previously closed at $46.29, but opened at $44.46. Avidity Biosciences shares last traded at $44.45, with a volume of 505,071 shares. Specifically, insider Steven George Hughes sold […] - 2025-08-12 02:18:50
Barclays Increases Avidity Biosciences (NASDAQ:RNA) Price Target to $62.00: Avidity Biosciences (NASDAQ:RNA – Free Report) had its price target boosted by Barclays from $59.00 to $62.00 in a research note released on Friday,Benzinga reports. Barclays currently has an overweight rating on the biotechnology company’s stock. A number of other brokerages also recently commented on RNA. Bank of America lifted their price objective on Avidity […] - 2025-08-11 03:50:56
Oppenheimer Asset Management Inc. Invests $226,000 in Avidity Biosciences, Inc. (NASDAQ:RNA): Oppenheimer Asset Management Inc. bought a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the first quarter, Holdings Channel reports. The fund bought 7,657 shares of the biotechnology company’s stock, valued at approximately $226,000. Several other hedge funds have also modified their holdings of the stock. Parallel Advisors LLC raised […] - 2025-07-01 04:52:51
The Implied Analyst 12-Month Target For ESML: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-26 13:02:45
Avidity Biosciences (NASDAQ:RNA) Now Covered by Sanford C. Bernstein: Investment analysts at Sanford C. Bernstein began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage set an “outperform” rating and a $50.00 price target on the biotechnology company’s stock. Sanford C. Bernstein’s price target indicates a potential upside of […] - 2025-06-26 02:48:48
Avidity Biosciences (NASDAQ:RNA) Earns Outperform Rating from Analysts at Wolfe Research: Equities research analysts at Wolfe Research assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research note issued on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $55.00 price target on the biotechnology company’s stock. Wolfe Research’s price objective points to a potential upside of 87.59% from […] - 2025-06-19 02:42:48
Assenagon Asset Management S.A. Raises Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA): Assenagon Asset Management S.A. raised its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 411.3% during the 1st quarter, Holdings Channel reports. The fund owned 207,372 shares of the biotechnology company’s stock after purchasing an additional 166,813 shares during the period. Assenagon Asset Management S.A.’s holdings in Avidity Biosciences were worth […] - 2025-06-15 05:44:49
Chardan Capital Forecasts Strong Price Appreciation for Avidity Biosciences (NASDAQ:RNA) Stock: Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its price objective raised by research analysts at Chardan Capital from $65.00 to $75.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Chardan Capital’s price target would indicate a potential upside of 123.08% from the company’s […] - 2025-06-11 04:58:52
Avidity Biosciences (NASDAQ:RNA) Stock Price Expected to Rise, Bank of America Analyst Says: Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its price objective hoisted by stock analysts at Bank of America from $48.00 to $54.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price target would indicate a potential upside of 60.62% from […] - 2025-06-11 03:00:54
Avidity Biosciences (NASDAQ:RNA) Shares Gap Up Following Analyst Upgrade: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) shares gapped up before the market opened on Monday after Citigroup raised their price target on the stock from $70.00 to $75.00. The stock had previously closed at $36.24, but opened at $38.00. Citigroup currently has a buy rating on the stock. Avidity Biosciences shares last traded […] - 2025-06-11 02:08:44
Traders Purchase Large Volume of Avidity Biosciences Put Options (NASDAQ:RNA): Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) was the target of unusually large options trading activity on Wednesday. Stock traders acquired 7,058 put options on the company. This is an increase of 1,411% compared to the typical daily volume of 467 put options. Avidity Biosciences Price Performance Shares of Avidity Biosciences stock opened at […] - 2025-06-06 05:14:54
Brokerages Set Avidity Biosciences, Inc. (NASDAQ:RNA) Price Target at $66.38: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned a consensus recommendation of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat.com reports. Thirteen research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued a report on the stock in […] - 2025-06-04 02:36:49

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) RNA holdings

Date	Number of RNA Shares Held	Base Market Value of RNA Shares	Local Market Value of RNA Shares	Change in RNA Shares Held	Change in RNA Base Value	Current Price per RNA Share Held	Previous Price per RNA Share Held
2025-11-11 (Tuesday)	83,196	USD 5,881,957	USD 5,881,957	0	USD 71,548	USD 70.7	USD 69.84
2025-11-10 (Monday)	83,196	USD 5,810,409	USD 5,810,409	213	USD 14,876	USD 69.84	USD 69.84
2025-11-07 (Friday)	82,983	USD 5,795,533	USD 5,795,533	0	USD 4,979	USD 69.84	USD 69.78
2025-11-06 (Thursday)	82,983	USD 5,790,554	USD 5,790,554	213	USD 13,208	USD 69.78	USD 69.8
2025-11-05 (Wednesday)	82,770	USD 5,777,346	USD 5,777,346	0	USD -2,483	USD 69.8	USD 69.83
2025-11-04 (Tuesday)	82,770	USD 5,779,829	USD 5,779,829	213	USD 17,350	USD 69.83	USD 69.8
2025-11-03 (Monday)	82,557	USD 5,762,479	USD 5,762,479	0	USD -4,127	USD 69.8	USD 69.85
2025-10-31 (Friday)	82,557	USD 5,766,606	USD 5,766,606	0	USD 13,209	USD 69.85	USD 69.69
2025-10-30 (Thursday)	82,557	USD 5,753,397	USD 5,753,397	1,065	USD 77,479	USD 69.69	USD 69.65
2025-10-29 (Wednesday)	81,492	USD 5,675,918	USD 5,675,918	426	USD 6,973	USD 69.65	USD 69.93
2025-10-28 (Tuesday)	81,066	USD 5,668,945	USD 5,668,945	0	USD -5,675	USD 69.93	USD 70
2025-10-27 (Monday)	81,066	USD 5,674,620	USD 5,674,620	0	USD 1,690,226	USD 70	USD 49.15

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RNA by Blackrock for IE00BYXG2H39

Show aggregate share trades of RNA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 213 69.865 69.770 69.779 USD 14,863 36.87
2025-11-06 BUY 213 69.860 69.770 69.779 USD 14,863 36.53
2025-11-04 BUY 213 69.870 69.760 69.771 USD 14,861 36.19
2025-10-30 BUY 1,065 69.830 69.500 69.533 USD 74,053 35.66
2025-10-29 BUY 426 69.650 69.950 69.920 USD 29,786 35.48
2025-10-22 SELL -852 46.860 49.500 49.236 USD -41,949 34.90 Loss of -12,214 on sale
2025-10-20 BUY 426 49.010 50.220 50.099 USD 21,342 34.75
2025-10-17 BUY 1,065 47.890 49.380 49.231 USD 52,431 34.67
2025-10-15 BUY 1,704 50.470 51.490 51.388 USD 87,565 34.59
2025-10-03 BUY 1,484 47.000 47.300 47.270 USD 70,149 34.44
2025-10-02 BUY 212 44.180 44.190 44.189 USD 9,368 34.39
2025-09-30 BUY 424 43.570 43.690 43.678 USD 18,519 34.29
2025-09-26 BUY 424 42.950 43.120 43.103 USD 18,276 34.19
2025-09-25 BUY 424 40.840 43.320 43.072 USD 18,263 34.15
2025-09-24 BUY 1,020 43.210 44.500 44.371 USD 45,258 34.10
2025-09-18 BUY 208 41.810 41.920 41.909 USD 8,717 34.05
2025-09-17 BUY 627 40.060 42.415 42.180 USD 26,447 34.02
2025-08-20 SELL -832 44.340 44.405 44.398 USD -36,940 33.77 Loss of -8,843 on sale
2025-07-30 BUY 832 36.880 39.000 38.788 USD 32,272 33.44
2025-07-17 SELL -416 34.040 34.540 34.490 USD -14,348 33.38 Loss of -462 on sale
2025-07-16 BUY 826 33.530 33.950 33.908 USD 28,008 33.38
2025-07-11 SELL -1,648 31.450 32.550 32.440 USD -53,461 33.40 Profit of 1,586 on sale
2025-07-07 BUY 618 28.800 29.290 29.241 USD 18,071 33.49
2025-07-02 BUY 11,330 29.360 29.575 29.554 USD 334,841 33.55
2025-06-20 BUY 1,902 29.310 29.650 29.616 USD 56,330 33.58
2025-06-11 BUY 400 32.010 34.390 34.152 USD 13,661 33.75
2025-06-10 BUY 400 33.620 34.784 34.668 USD 13,867 33.75
2025-06-04 SELL -200 34.220 35.210 35.111 USD -7,022 33.72 Loss of -279 on sale
2025-04-23 BUY 200 30.680 31.580 31.490 USD 6,298 34.68
2025-04-10 SELL -1,600 24.110 24.490 24.452 USD -39,123 35.48 Profit of 17,651 on sale
2025-04-08 SELL -200 24.080 27.831 27.456 USD -5,491 35.74 Profit of 1,656 on sale
2025-04-07 SELL -200 25.480 27.450 27.253 USD -5,451 35.86 Profit of 1,721 on sale
2025-04-04 SELL -1,000 26.570 27.825 27.700 USD -27,700 35.97 Profit of 8,267 on sale
2025-04-01 BUY 1,748 26.740 29.380 29.116 USD 50,895 36.15
2025-03-31 SELL -591 29.520 30.245 30.173 USD -17,832 36.23 Profit of 3,582 on sale
2025-03-21 BUY 2,995 30.840 31.230 31.191 USD 93,417 36.56
2025-03-14 SELL -2,992 31.110 33.160 32.955 USD -98,601 36.91 Profit of 11,836 on sale
2025-03-07 SELL -374 30.290 30.970 30.902 USD -11,557 37.36 Profit of 2,417 on sale
2025-03-04 SELL -187 28.560 29.150 29.091 USD -5,440 37.74 Profit of 1,617 on sale
2025-02-25 BUY 374 29.160 31.180 30.978 USD 11,586 38.45
2025-02-19 SELL -187 31.900 32.370 32.323 USD -6,044 38.96 Profit of 1,241 on sale
2025-02-13 BUY 561 33.020 33.190 33.173 USD 18,610 39.48
2025-02-12 BUY 187 31.830 33.000 32.883 USD 6,149 39.64
2025-02-11 BUY 748 33.790 34.140 34.105 USD 25,511 39.76
2024-12-30 SELL -5,441 29.180 29.990 29.909 USD -162,735 43.15 Profit of 72,051 on sale
2024-11-18 SELL -3,015 41.350 42.320 42.223 USD -127,302 45.34 Profit of 9,409 on sale
2024-11-08 SELL -201 46.720 47.295 47.237 USD -9,495 45.15 Loss of -420 on sale
2024-10-21 SELL -201 46.710 50.400 50.031 USD -10,056 0.00 Loss of -10,056 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	213	69.865	69.770	69.779	USD 14,863	36.87
2025-11-06	BUY	213	69.860	69.770	69.779	USD 14,863	36.53
2025-11-04	BUY	213	69.870	69.760	69.771	USD 14,861	36.19
2025-10-30	BUY	1,065	69.830	69.500	69.533	USD 74,053	35.66
2025-10-29	BUY	426	69.650	69.950	69.920	USD 29,786	35.48
2025-10-22	SELL	-852	46.860	49.500	49.236	USD -41,949	34.90 Loss of -12,214 on sale
2025-10-20	BUY	426	49.010	50.220	50.099	USD 21,342	34.75
2025-10-17	BUY	1,065	47.890	49.380	49.231	USD 52,431	34.67
2025-10-15	BUY	1,704	50.470	51.490	51.388	USD 87,565	34.59
2025-10-03	BUY	1,484	47.000	47.300	47.270	USD 70,149	34.44
2025-10-02	BUY	212	44.180	44.190	44.189	USD 9,368	34.39
2025-09-30	BUY	424	43.570	43.690	43.678	USD 18,519	34.29
2025-09-26	BUY	424	42.950	43.120	43.103	USD 18,276	34.19
2025-09-25	BUY	424	40.840	43.320	43.072	USD 18,263	34.15
2025-09-24	BUY	1,020	43.210	44.500	44.371	USD 45,258	34.10
2025-09-18	BUY	208	41.810	41.920	41.909	USD 8,717	34.05
2025-09-17	BUY	627	40.060	42.415	42.180	USD 26,447	34.02
2025-08-20	SELL	-832	44.340	44.405	44.398	USD -36,940	33.77 Loss of -8,843 on sale
2025-07-30	BUY	832	36.880	39.000	38.788	USD 32,272	33.44
2025-07-17	SELL	-416	34.040	34.540	34.490	USD -14,348	33.38 Loss of -462 on sale
2025-07-16	BUY	826	33.530	33.950	33.908	USD 28,008	33.38
2025-07-11	SELL	-1,648	31.450	32.550	32.440	USD -53,461	33.40 Profit of 1,586 on sale
2025-07-07	BUY	618	28.800	29.290	29.241	USD 18,071	33.49
2025-07-02	BUY	11,330	29.360	29.575	29.554	USD 334,841	33.55
2025-06-20	BUY	1,902	29.310	29.650	29.616	USD 56,330	33.58
2025-06-11	BUY	400	32.010	34.390	34.152	USD 13,661	33.75
2025-06-10	BUY	400	33.620	34.784	34.668	USD 13,867	33.75
2025-06-04	SELL	-200	34.220	35.210	35.111	USD -7,022	33.72 Loss of -279 on sale
2025-04-23	BUY	200	30.680	31.580	31.490	USD 6,298	34.68
2025-04-10	SELL	-1,600	24.110	24.490	24.452	USD -39,123	35.48 Profit of 17,651 on sale
2025-04-08	SELL	-200	24.080	27.831	27.456	USD -5,491	35.74 Profit of 1,656 on sale
2025-04-07	SELL	-200	25.480	27.450	27.253	USD -5,451	35.86 Profit of 1,721 on sale
2025-04-04	SELL	-1,000	26.570	27.825	27.700	USD -27,700	35.97 Profit of 8,267 on sale
2025-04-01	BUY	1,748	26.740	29.380	29.116	USD 50,895	36.15
2025-03-31	SELL	-591	29.520	30.245	30.173	USD -17,832	36.23 Profit of 3,582 on sale
2025-03-21	BUY	2,995	30.840	31.230	31.191	USD 93,417	36.56
2025-03-14	SELL	-2,992	31.110	33.160	32.955	USD -98,601	36.91 Profit of 11,836 on sale
2025-03-07	SELL	-374	30.290	30.970	30.902	USD -11,557	37.36 Profit of 2,417 on sale
2025-03-04	SELL	-187	28.560	29.150	29.091	USD -5,440	37.74 Profit of 1,617 on sale
2025-02-25	BUY	374	29.160	31.180	30.978	USD 11,586	38.45
2025-02-19	SELL	-187	31.900	32.370	32.323	USD -6,044	38.96 Profit of 1,241 on sale
2025-02-13	BUY	561	33.020	33.190	33.173	USD 18,610	39.48
2025-02-12	BUY	187	31.830	33.000	32.883	USD 6,149	39.64
2025-02-11	BUY	748	33.790	34.140	34.105	USD 25,511	39.76
2024-12-30	SELL	-5,441	29.180	29.990	29.909	USD -162,735	43.15 Profit of 72,051 on sale
2024-11-18	SELL	-3,015	41.350	42.320	42.223	USD -127,302	45.34 Profit of 9,409 on sale
2024-11-08	SELL	-201	46.720	47.295	47.237	USD -9,495	45.15 Loss of -420 on sale
2024-10-21	SELL	-201	46.710	50.400	50.031	USD -10,056	0.00 Loss of -10,056 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RNA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	479,193	730	670,240	71.5%
2025-09-18	554,478	0	762,941	72.7%
2025-09-17	562,186	8,483	864,658	65.0%
2025-09-16	474,349	8,279	736,380	64.4%
2025-09-15	1,254,254	53,512	2,429,041	51.6%
2025-09-12	1,851,579	59,324	3,704,572	50.0%
2025-09-11	2,661,160	79,723	4,334,246	61.4%
2025-09-10	533,839	2,174	1,145,716	46.6%
2025-09-09	711,392	589	1,263,078	56.3%
2025-09-08	512,030	2,000	961,959	53.2%
2025-09-05	728,043	8,553	1,497,260	48.6%
2025-09-04	254,612	4,625	487,032	52.3%
2025-09-03	439,832	2,800	971,692	45.3%
2025-09-02	548,455	942	1,130,707	48.5%
2025-08-29	347,269	2,984	585,144	59.3%
2025-08-28	578,734	4,472	1,073,432	53.9%
2025-08-27	336,047	0	550,225	61.1%
2025-08-26	378,994	2,387	558,606	67.8%
2025-08-25	291,957	1,364	443,822	65.8%
2025-08-22	421,554	692	673,648	62.6%
2025-08-21	266,829	176	391,203	68.2%
2025-08-20	380,047	5,788	513,494	74.0%
2025-08-19	407,186	3,755	777,005	52.4%
2025-08-18	409,017	559	711,246	57.5%
2025-08-15	644,114	11,248	1,061,732	60.7%
2025-08-14	518,133	4,263	934,468	55.4%
2025-08-13	470,039	6,345	1,247,535	37.7%
2025-08-12	644,525	1,910	1,247,028	51.7%
2025-08-11	630,303	1,012	1,400,171	45.0%
2025-08-08	1,234,510	7,440	1,550,082	79.6%
2025-08-07	968,859	9,462	1,759,643	55.1%
2025-08-06	4,793,692	51,980	7,935,195	60.4%
2025-08-05	629,962	300	815,840	77.2%
2025-08-04	714,343	2,536	909,307	78.6%
2025-08-01	617,309	125	914,039	67.5%
2025-07-31	719,980	1,251	991,994	72.6%
2025-07-30	982,398	4,488	1,328,739	73.9%
2025-07-29	840,665	611	1,127,354	74.6%
2025-07-28	950,575	200	1,206,410	78.8%
2025-07-25	1,580,852	2,029	2,976,369	53.1%
2025-07-24	208,086	524	359,808	57.8%
2025-07-23	370,509	930	653,642	56.7%
2025-07-22	302,007	212	452,625	66.7%
2025-07-21	489,543	101	967,132	50.6%
2025-07-18	779,140	101	1,270,545	61.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE